Back Human Papillomavirus (HPV)

Human Papillomavirus (HPV)

Cervarix Vaccine Protects Women against HPV that Causes Anal Cancer

The Cervarix human papillomavirus (HPV) vaccine reduced anal infection with cancer-causing HPV types 16 and 18 in a study of women in Costa Rica, according to a report in the September 2011 issue of The Lancet Oncology.alt

Read more:

HPV Vaccine Reduces Cervical Abnormalities

Vaccination of young women in Australia against human papillomavirus (HPV) lowered incidence of serious cervical cell abnormalities and early cervical cancer by nearly 40%. alt

Read more:

Researchers Develop HPV Protein Inhibitor

Researchers constructed a recombinant protein that interferes with the human papillomavirus (HPV) E2 protein, inhibiting viral replication and its ability to cause cancer. alt

Read more:

Lopinavir Fights HPV in Cervical Cancer Cells

The HIV protease inhibitor lopinavir (the main drug in Kaletra) blocked viral proteasome activitation and selectively killed pre-cancerous cervical cells infected with human papillomavirus (HPV).

As reported in the May 3, 2011, advance online edition of Antiviral Therapy, Gavin Batman and Ian Hampson from the University of Manchester in the U.K. and colleagues tested lopinavir in HPV-infected SiHa cervical carcinoma cells in a laboratory study.

Read more:

FDA Approves New Human Papillomavirus Test

The FDA this week approved Roche's new human papillomavirus test, which identifies genotypes of cancer-causing HPV types 16 and 18, as well as detecting 12 other high-risk types. alt

Read more: